Page last updated: 2024-08-23

vindesine and Melanoma

vindesine has been researched along with Melanoma in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	35 (46.05)	18.7374
1990's	24 (31.58)	18.2507
2000's	15 (19.74)	29.6817
2010's	2 (2.63)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aumann, J; Behrens, D; Fichtner, I; Freundt, G; Kobelt, D; Lemm, M; Schlag, PM; Schmidt, M; Walther, W; Wittig, B	1
Abdel Jaoued, A; Attaoua, C; Baï, Q; Cuq, P; De Vos, J; Hadj-Kaddour, K; Vian, L; Vincent, LA	1
Eigentler, TK; Ellwanger, U; Garbe, C; Gutzmer, R; Hauschild, A; Linse, R; Pföhler, C; Radny, P; Schadendorf, D; Wagner, SN	1
Egberts, F; Hauschild, A; Hitschler, WN; Weichenthal, M	1
Henry, K; Pectasides, D; Quigley, M; Retsas, S	1
Egyházi, S; Hansson, J; Ma, S; Martenhed, G; Ringborg, U	1
Cappugi, P; Coronnello, M; Giannotti, B; Mini, E; Pimpinelli, N; Prignano, F	1
Acito, L; Bacchi, M; Beretta, M; Carlini, P; Cocconi, G; Di Sarra, S; Foladore, S; Gebbia, V; Maiello, E; Marchi, M; Passalacqua, R	1
Emmert, S; Haenssle, H; Kretschmer, L; Neumann, C; Zutt, M	1
Baraldi, PG; Borea, PA; Capitani, S; Gessi, S; Leung, E; Merighi, S; Mirandola, P; Tabrizi, MA; Varani, K	1
Egyházi, S; Hansson, J; Kreklau, EL; Lindholm, C; Ma, S; Ringborg, U; Stierner, U; Ueno, T	1
Eigentler, TK; Garbe, C	1
Brennecke, S; Deichmann, M; Kurzen, H; Naeher, H	1
Hofmann, MA; Sterry, W; Trefzer, U	1
Gaukroger, JM; MacKie, RM; Wilson, L	1
Kleeberg, UR; Voigt, H	1
Aigner, KR; Börger, G; Illig, L; Jungbluth, A; Link, KH; Müller, H; Ringenberg, T; Ruppel, R; Schwemmle, K; Walther, H	1
Balda, BR; Jehn, U; Klövekorn, W; Wohlrab, A	1
Beltran, J; Costa, RR; Lopez, JJ; Mayol, XF; Rifa, J; Rubio-Bazan, R	1
Donoso, JA; Himes, RH	1
Gaukroger, JM; Gold, J; MacKie, RM; Wilson, L	1
Berris, R; DiBella, NJ; Fink, K; Garfield, D; Sakamoto, A; Speer, J	1
Conroy, JA; Nelimark, RA; Peterson, BA; Vosika, GJ	1
Czarnetzki, B; Everall, JD; Mulder, JH; Rozencweig, M; Rümke, P; Thomas, D	1
Baker, LH; Costanzi, JJ; Quagliana, JM; Stephens, RL	1
Anderson, HA; Shiu, W; Thatcher, N; Wagstaff, J	1
Atkinson, RJ; Calman, KC; Carmichael, J; Mackie, RM; Naysmith, AM; Smyth, JF	1
Cavalli, F; Clavel, M; Czarnetzki, B; Dodion, P; Mulder, JH; Rozencweig, M; Suciu, S; Thomas, D	1
Talpaz, M; Yancey, RS	1
Hobbs, JR; Retsas, S; Thomas, C	1
Camacho, FJ; Wittes, RE; Young, CW	1
Ashford, R; Coe, M; Drury, A; Hanham, IW; Maher, J; Newton, KA; Peat, I; Phillips, RH; Retsas, S; Westbury, G	1
Dubois, JB; el Amrani, N; Mathieu-Daude, H; Melhouf, MM	1
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M	1
Dreno, B; Mansat-Krzyzanowska, E	1
Bezwoda, WR; Vorobiof, DA	1
Henry, K; Macrae, K; Pectasides, D; Quigley, M; Retsas, S	1
Alevizakos, N; Asimakopoulos, G; Athanassiou, A; Bafaloukos, D; Dimitriadis, M; Pectasides, D; Tzonou, A; Varthalitis, I	1
Burgess, MA; Hersh, EM; Legha, SS; Papadopoulos, N; Plager, C; Verschraegen, CF	1
Aamdal, S; Boeryd, B; Carstensen, J; Jungnelius, U; Kågedal, B; Karlsson, M; Westberg, R; Wingren, S	1
Antoine, E; Auclerc, G; Benhammouda, A; Bizzari, JP; Borel, C; Paraiso, D; Petit, T; Rixe, O; Soubrane, C; Weil, M	1
Cavillon, C; Claude, R; Desplechain, C; Egloff, H; Franck, F; Goujon, N; Lautier, A; Plagne, R; Rigondet, G; Sale, JM	1
Dancey, J; Steward, WP	1
Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E	1
Christmann, M; Dietel, M; Kaina, B; Kern, MA; Lage, H; Pick, M; Schadendorf, D	1
Bajetta, E; Barduagni, L; Bernengo, MG; Bufalino, R; Cascinelli, N; Comella, G; Criscuolo, D; Del Vecchio, M; DelVecchio, M; Morabito, A; Queirolo, P; Sertoli, MR; Vecchio, S	1
Kern, MA; Lichter, P; Nessling, M; Schadendorf, D	1
Green, JA; Iqbal, M; Marshall, E	1
Deraemaecker, R; Sales, F; Vandeweyer, E	1
Retsas, S	1
Doherty, VR; MacKie, RM; Stables, GI	1
Garbe, C; Kreuser, ED; Orfanos, CE; Stadler, R; Zouboulis, CC	1
Kubota, K; Kubota, R; Yamada, S	1
Avril, MF; Bertrand, P; Bizzari, JP; Cour, V; Gerard, B; Khayat, D	1
Bafaloukos, D; Photiou, A; Retsas, S; Sheikh, MN	1
Eccles, JM; Green, JA; Smith, KA	1
Bliss, JM; Gore, ME; Lakhani, S; McElwain, TJ; Perren, TJ; Selby, P	1
Glover, DJ	1
Hansson, J; Jungnelius, U; Ringborg, U; Strander, H	1
De Vries, EG; Koops, HS; Mulder, NH; Sleijfer, DT; Smit, JM; Willemse, PH	1
de Vries, EG; Mulder, NH; Samson, MJ; Schraffordt Koops, H; Sleijfer, DT; Willemse, PH	1
Cartei, G; Ceschia, T; Clocchiatti, L; Fasola, G; Galletti, D; Marsilio, P; Morandini, G; Sibau, A	1
English, JS; Lever, RS; MacKie, RM; Young, DW	1
Bijzet, J; Bouman, J; Jurjens, H; Mulder, NH; Sleijfer, DT; Smit, JM; Woldring, MG	1
Hafström, L; Hansson, J; Ringborg, U; Rudenstam, CM; Stenstam, B; Strander, H	1
Alevizakos, N; Athanassiou, A; Bafaloukos, D; Barbounis, V; Dimitriadis, M; Pectasides, D; Varthalitis, J; Yianniotis, H	1
Engelhardt, R	1
de Garis, ST; Dische, S; Nelstrop, A; Rustin, GJ	1
Czarnetzki, B; Kleeberg, UR; Mulder, J; Rozencweig, M; Rumke, P; Suciu, S; Thomas, D; Truchetet, F; Verschraegen, CF	1
Carmo-Pereira, J; Costa, FO; Henriques, E	1
Gundersen, S	1
Falkson, G; Sarli, R; Vorobiof, DA	1
Axton, CA; Baldwin, RW; Brown, JP; Corvalan, JR; Embleton, MJ; Gore, VA; Hellström, I; Hellström, KE; Jacobs, E; Rowland, GF	1
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S	1
Himes, RH; Jordan, MA; Wilson, L	1
Gaukroger, JM; MacKie, R; Wilson, L	1

Reviews

5 review(s) available for vindesine and Melanoma

Article	Year
[Therapy of malignant melanoma at the stage of distant metastasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine	2004
The role of vindesine in oncology--recommendations after 10 years' experience. Anti-cancer drugs, 1995, Volume: 6, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Humans; Leukemia; Lung Neoplasms; Lymphoma; Melanoma; Vindesine	1995
Adjuvant therapy of malignant melanoma: is there a choice? Critical reviews in oncology/hematology, 2001, Volume: 40, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Follow-Up Studies; Humans; Interferons; Lymphatic Metastasis; Melanoma; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Staging; Premedication; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vindesine	2001
Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dacarbazine; Humans; Interferons; Melanoma; Vinblastine; Vindesine	1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma. Melanoma research, 1992, Volume: 2, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine	1992

Trials

16 trial(s) available for vindesine and Melanoma

Article	Year
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group. Melanoma research, 2008, Volume: 18, Issue:5 Topics: Adult; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Skin Neoplasms; Survival Rate; Vindesine	2008
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse. Melanoma research, 2009, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Prospective Studies; Recombinant Proteins; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Vindesine	2009
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study. Melanoma research, 2003, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Survival Rate; Tamoxifen; Treatment Outcome; Vindesine	2003
Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents. Melanoma research, 2003, Volume: 13, Issue:3 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Salvage Therapy; Skin Neoplasms; Treatment Outcome; Vindesine	2003
Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma. Melanoma research, 2005, Volume: 15, Issue:6 Topics: Adult; Aged; Angiogenic Proteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Fibroblast Growth Factor 2; Humans; Interferon-alpha; Interleukin-2; Interleukin-8; Male; Melanoma; Middle Aged; Neoplasm Staging; Platelet-Derived Growth Factor; Prospective Studies; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vindesine	2005
A randomised trial of vindesine plus interferon-alpha 2b compared with interferon-alpha 2b or vindesine alone in the treatment of advanced malignant melanoma. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:6 Topics: Combined Modality Therapy; Female; Humans; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Recombinant Proteins; Soft Tissue Neoplasms; Vindesine	1994
Adjuvant chemotherapy with dacarbazine, vindesine, and cisplatin in pathological stage II malignant melanoma. American journal of clinical oncology, 1994, Volume: 17, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Dacarbazine; Female; Humans; Life Tables; Male; Melanoma; Middle Aged; Neoplasm Staging; Survival Analysis; Vindesine	1994
Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5 Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Dacarbazine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Prognosis; Vindesine	1993
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. International journal of cancer, 1996, Jan-03, Volume: 65, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; DNA, Neoplasm; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Ploidies; Regression Analysis; S Phase; Survival Analysis; Vindesine	1996
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients. Melanoma research, 1995, Volume: 5, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine	1995
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting	1998
Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma). Melanoma research, 1999, Volume: 9, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Recombinant Proteins; Survival Rate; Tamoxifen; Treatment Outcome; Vindesine	1999
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma. Melanoma research, 1992, Volume: 2, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine	1992
Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Vindesine	1989
Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Procarbazine; Prospective Studies; Random Allocation; Skin Neoplasms; Vindesine	1986
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting	1985

Other Studies

56 other study(ies) available for vindesine and Melanoma

Article	Year
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector. Molecular oncology, 2014, Volume: 8, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DNA; Female; Genetic Therapy; Genetic Vectors; Humans; Melanoma; Mice; Transfection; Transgenes; Tumor Necrosis Factor-alpha; Vindesine	2014
Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids. Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:1 Topics: Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Melanoma; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Vinblastine; Vinca Alkaloids; Vindesine; Vinorelbine	2015
Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008). Melanoma research, 2009, Volume: 19, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Humans; Lymphatic Metastasis; Melanoma; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Vindesine	2009
Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy. Melanoma research, 2002, Volume: 12, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; DNA Damage; DNA Methylation; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Observer Variation; Prodrugs; Vindesine	2002
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. Cancer letters, 2002, Dec-05, Volume: 186, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Humans; Immunophenotyping; Inhibitory Concentration 50; Interferon alpha-2; Interferon-alpha; Melanoma; Microscopy, Electron; Neoplasm Metastasis; Paclitaxel; Recombinant Proteins; Temozolomide; Time Factors; Tumor Cells, Cultured; Vindesine	2002
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemotherapic drugs: taxol and vindesine. Biochemical pharmacology, 2003, Sep-01, Volume: 66, Issue:5 Topics: Antineoplastic Agents; Cell Cycle; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Keratinocytes; Melanoma; Paclitaxel; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A3; Triazoles; Tumor Cells, Cultured; Vindesine	2003
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. British journal of cancer, 2003, Oct-20, Volume: 89, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Genetic; Skin Neoplasms; Treatment Outcome; Vindesine	2003
Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit? Japanese journal of clinical oncology, 2007, Volume: 37, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vindesine	2007
Validation of in vitro chemosensitivity testing in malignant melanoma. Lancet (London, England), 1983, Mar-12, Volume: 1, Issue:8324 Topics: Cells, Cultured; Drug Resistance; Humans; Melanoma; Skin Neoplasms; Vinblastine; Vindesine	1983
PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study. Cancer, 1984, May-15, Volume: 53, Issue:10 Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Bone Marrow; Cisplatin; Drug Eruptions; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Phosphonoacetic Acid; Pilot Projects; Vinblastine; Vindesine; Vomiting	1984
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas]. Onkologie, 1984, Volume: 7, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Humans; Leg; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Skin Neoplasms; Vinblastine; Vindesine	1984
[Pilot study with vindesine as monotherapy in metastatic malignant melanomas]. MMW, Munchener medizinische Wochenschrift, 1983, Jan-21, Volume: 125, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine	1983
Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma. Cancer treatment reports, 1984, Volume: 68, Issue:9 Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1984
The action of two Vinca alkaloids on B16 melanoma in vitro. Cancer biochemistry biophysics, 1984, Volume: 7, Issue:2 Topics: Animals; Biological Transport; Cells, Cultured; Female; Graft Survival; Melanoma; Mice; Neoplasm Transplantation; Vinblastine; Vincristine; Vindesine	1984
Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma. Cancer treatment reports, 1984, Volume: 68, Issue:9 Topics: Adult; Aged; Colony-Forming Units Assay; Evaluation Studies as Topic; Female; Humans; Male; Melanoma; Middle Aged; Tumor Stem Cell Assay; Vinblastine; Vindesine	1984
Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study. Investigational new drugs, 1984, Volume: 2, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Lymphoma; Melanoma; Middle Aged; Vinblastine; Vindesine	1984
Vindesine for metastatic malignant melanoma. A phase II trial. American journal of clinical oncology, 1983, Volume: 6, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nervous System; Skin Neoplasms; Vinblastine; Vindesine	1983
EORTC phase II trial of vindesine in advanced melanoma. European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1983
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:4 Topics: Adult; Aged; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nervous System Diseases; Skin Neoplasms; Thrombocytopenia; Vinblastine; Vindesine	1984
Phase II study of vindesine infusion in visceral metastatic malignant melanoma. Cancer treatment reports, 1983, Volume: 67, Issue:9 Topics: Adult; Aged; Drug Evaluation; Humans; Infusions, Parenteral; Melanoma; Middle Aged; Neoplasm Metastasis; Vinblastine; Vindesine	1983
A multicentre phase II trial of vindesine in malignant melanoma. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:12 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1982
Vindesine-associated angina and ECG changes. Cancer treatment reports, 1982, Volume: 66, Issue:3 Topics: Adenocarcinoma; Aged; Angina Pectoris; Antineoplastic Agents; Electrocardiography; Humans; Male; Melanoma; Middle Aged; Sigmoid Neoplasms; Vinblastine; Vindesine	1982
The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma. Clinical oncology, 1981, Volume: 7, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Lymphocytes; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1981
Phase II trial of vindesine in patients with malignant melanoma. Cancer treatment reports, 1980, Volume: 64, Issue:1 Topics: Adult; Anemia; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Paresthesia; Time Factors; Vinblastine; Vindesine	1980
Update results of vindesine as a single agent in the therapy of advanced malignant melanoma. Cancer treatment reviews, 1980, Volume: 7 Suppl 1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Vinblastine; Vindesine	1980
[Anorectal malignant melanomas. Apropos of 5 cases. Review of the literature]. Annales de gastroenterologie et d'hepatologie, 1995, Volume: 31, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Vindesine	1995
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer, 1994, Jan-01, Volume: 73, Issue:1 Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine	1994
[Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma]. Annales de dermatologie et de venereologie, 1994, Volume: 121, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Interferon-alpha; Male; Melanoma; Treatment Outcome; Vindesine	1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival. Cancer, 1994, Apr-15, Volume: 73, Issue:8 Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Proportional Hazards Models; Prospective Studies; Survival Analysis; Vindesine	1994
[A case of adrenal gland metastasis of a cutaneous melanoma treated by excision with 3-year survival]. Annales d'urologie, 1996, Volume: 30, Issue:1 Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Follow-Up Studies; Humans; Male; Melanoma; Skin Neoplasms; Vindesine	1996
Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. International journal of cancer, 1999, Mar-01, Volume: 80, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carrier Proteins; Cisplatin; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; Drug Resistance, Multiple; Etoposide; Humans; Melanoma; MutL Protein Homolog 1; MutS Homolog 2 Protein; N-Glycosyl Hydrolases; Neoplasm Proteins; Nitrosourea Compounds; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA, Messenger; Transcription, Genetic; Vindesine	1999
Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines. Cytogenetics and cell genetics, 1999, Volume: 87, Issue:3-4 Topics: Aneuploidy; Antineoplastic Agents; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 9; Cisplatin; DNA Mutational Analysis; DNA Probes; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Etoposide; Genome, Human; Humans; Melanoma; Nitrosourea Compounds; Nucleic Acid Hybridization; Organophosphorus Compounds; Selection, Genetic; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Vindesine	1999
Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Interferon-alpha; Liver Neoplasms; Male; Melanoma; Skin Neoplasms; Vindesine	2000
Cutaneous malignant melanoma in children. European journal of pediatrics, 2000, Volume: 159, Issue:8 Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dacarbazine; Female; Follow-Up Studies; Humans; Infant; Male; Melanoma; Neoplasm Staging; Prognosis; Risk Factors; Skin Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Vindesine	2000
Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma. The British journal of dermatology, 1992, Volume: 127, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Survival Rate; Vindesine	1992
[Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:13 Topics: Alkaloids; Benzylisoquinolines; Drug Synergism; Etoposide; Humans; Melanoma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine	1992
Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:4 Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Colony-Forming Units Assay; Humans; Melanoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vinblastine; Vincristine; Vindesine; Vinorelbine	1992
Interferon alpha 2a and vindesine in the treatment of advanced malignant melanoma. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Adult; Aged; Combined Modality Therapy; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Recombinant Proteins; Vindesine	1992
Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit. British journal of cancer, 1990, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Vincristine; Vindesine	1990
New approaches to the chemotherapy of melanoma. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5 Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine	1991
Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial. American journal of clinical oncology, 1990, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Humans; Melanoma; Neoplasm Metastasis; Remission Induction; Vindesine	1990
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dactinomycin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Vindesine	1986
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma. Journal of cancer research and clinical oncology, 1989, Volume: 115, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Vindesine	1989
Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma. Tumori, 1989, Jun-30, Volume: 75, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Vindesine	1989
The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma. Cancer, 1985, May-01, Volume: 55, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine	1985
Spermidine level as a parameter in the treatment of patients with malignant melanoma. European journal of nuclear medicine, 1985, Volume: 10, Issue:5-6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dactinomycin; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Spermidine; Vinblastine; Vindesine	1985
Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin. British journal of cancer, 1989, Volume: 60, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Skin Neoplasms; Vindesine	1989
Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1988, Volume: 107 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Evaluation Studies as Topic; Female; Humans; Hyperthermia, Induced; Lung Neoplasms; Male; Melanoma; Vincristine; Vindesine	1988
Treatment of advanced malignant melanoma with interferon alpha and etretinate. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etretinate; Female; Humans; Interferon Type I; Male; Melanoma; Middle Aged; Skin Neoplasms; Vindesine	1988
Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group. Cancer, 1988, Sep-15, Volume: 62, Issue:6 Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Vindesine	1988
Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study. Cancer treatment reports, 1987, Volume: 71, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dacarbazine; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Vindesine; Vomiting	1987
Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma. Cancer treatment reports, 1986, Volume: 70, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Vindesine	1986
Antitumor properties of vindesine-monoclonal antibody conjugates. Cancer immunology, immunotherapy : CII, 1985, Volume: 19, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Vinblastine; Vindesine	1985
Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer research, 1985, Volume: 45, Issue:6 Topics: Animals; Antineoplastic Agents, Phytogenic; Cattle; Cell Division; In Vitro Techniques; Melanoma; Mice; Mice, Inbred C57BL; Microtubules; Tubulin; Vinblastine; Vincristine; Vindesine	1985
Cytotoxicity of etretinate and vindesine. British journal of cancer, 1985, Volume: 52, Issue:3 Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Etretinate; Humans; Melanoma; Mice; Vindesine	1985